ampreloxetine
ampreloxetine: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Theravance Biopharma, Inc. (TBPH) | Phase 3 |
Clinical Trials (1)
A Phase 3, Multi-center, Randomized Withdrawal and Long Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants With Multiple System Atrophy
Frequently asked questions
Who is developing ampreloxetine?
ampreloxetine is being developed by Theravance Biopharma, Inc..
How many clinical trials involve ampreloxetine?
BioSniper tracks 1 clinical trial involving ampreloxetine.
Get deeper analysis on ampreloxetine
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis